{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:12:58Z","timestamp":1763766778746,"version":"3.45.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,14]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Cancer-associated myositis (CAM) is a rare autoimmune disease linked to underlying malignancies and classified as an idiopathic inflammatory myopathy. It is characterized by a complex pathogenesis, poor prognosis, and diverse symptoms such as muscle weakness and myalgia, which may be accompanied by extramuscular manifestations. The presence of comorbidities in elderly patients can mask these symptoms, posing significant diagnostic and treatment challenges. Early recognition of CAM and detection of malignancy are crucial for improving patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 71-year-old male presented with progressive symmetrical proximal muscle pain as the sole manifestation, without typical extramuscular manifestations. Initial tests revealed negative muscle enzyme results, but electromyography indicated myogenic damage in the proximal muscles of the limbs. Further serological testing detected positive anti-TIF1\u03b3 and anti-PL-7 antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>The patient was diagnosed with CAM based on the presence of specific autoantibodies and a rapid clinical response to corticosteroids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Treatment with low-dose hormone therapy resulted in significant improvement of symptoms. A comprehensive malignancy screening was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Subsequent surgical pathology confirmed the presence of colon cancer. The patient\u2019s condition improved markedly with timely intervention and targeted treatment. At 6-month follow-up, he remained symptom-free.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case underscores the importance of considering CAM in patients with unexplained symmetrical proximal muscle pain, even in the absence of typical extramuscular symptoms. The detection of myositis-specific autoantibodies is critical for accurate diagnosis. Early identification and treatment of the underlying malignancy can significantly improve prognosis. Future research should focus on elucidating the pathogenesis of CAM, identifying more specific biomarkers, and developing standardized diagnostic and therapeutic guidelines to enhance early diagnosis and treatment outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046170","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:01:17Z","timestamp":1763154077000},"page":"e46170","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Progressive myalgia as the sole manifestation of cancer-associated myositis: A case report and review of the literature"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2815-4160","authenticated-orcid":false,"given":"Jian","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Rehabilitation, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People\u2019s Hospital, Quzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shucong","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuqing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People\u2019s Hospital, Quzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251121","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/biom12010111","article-title":"Update on malignancy in myositis-well-established association with unmet needs.","volume":"12","author":"Opinc","year":"2022","journal-title":"Biomolecules"},{"key":"R2-20251121","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies.","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20251121","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/S2665-9913(23)00322-3","article-title":"Idiopathic inflammatory myopathies: current insights and future frontiers.","volume":"6","author":"Connolly","year":"2024","journal-title":"Lancet Rheumatol"},{"issue":"Supplement","key":"R4-20251121","first-page":"S241","article-title":"Evolving classification and role of muscle biopsy in diagnosis of inflammatory myopathies.","volume":"65","author":"Swain","year":"2022","journal-title":"Indian J Pathol Microbiol"},{"key":"R5-20251121","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies.","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"R6-20251121","doi-asserted-by":"crossref","first-page":"152619","DOI":"10.1016\/j.semarthrit.2024.152619","article-title":"Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathies.","volume":"71","author":"Ceribelli","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"R7-20251121","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40674-022-00197-2","article-title":"Management of cancer-associated myositis.","volume":"8","author":"Selva-O\u2019Callaghan","year":"2022","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"R8-20251121","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/B978-0-444-63432-0.00025-6","article-title":"Autoimmune muscle disease.","volume":"133","author":"Mammen","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"R9-20251121","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/bs.acc.2024.04.001","article-title":"Autoantibody evaluation in idiopathic inflammatory myopathies.","volume":"120","author":"Tebo","year":"2024","journal-title":"Adv Clin Chem"},{"key":"R10-20251121","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/BOR.0000000000001044","article-title":"Clinical endpoints in myositis: challenges and ways forward.","volume":"36","author":"Ricco","year":"2024","journal-title":"Curr Opin Rheumatol"},{"issue":"Supplement","key":"R11-20251121","first-page":"S252","article-title":"Current approach to diagnosis of inflammatory myopathies: clinical features and myositis antibody profiles.","volume":"65","author":"Shobha","year":"2022","journal-title":"Indian J Pathol Microbiol"},{"key":"R12-20251121","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.neurol.2024.09.003","article-title":"Inflammatory myopathies in 2024: better classify them to better treat them.","volume":"180","author":"Benveniste","year":"2024","journal-title":"Rev Neurol (Paris)"},{"key":"R13-20251121","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/rheumatology\/kex413","article-title":"Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis.","volume":"57","author":"Pinal-Fernandez","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"R14-20251121","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1093\/rheumatology\/keab260","article-title":"TRIM33 gene somatic mutations identified by next generation sequencing in neoplasms of patients with anti-TIF1\u03b3 positive cancer-associated dermatomyositis.","volume":"60","author":"Cordel","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R15-20251121","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/1346-8138.15526","article-title":"Clinical features of anti-transcription intermediary factor 1\u03b3 (TIF1\u03b3)-positive dermatomyositis with internal malignancy and investigation of the involvement of TIF1\u03b3 expression in tumors in the pathogenesis of cancer-associated dermatomyositis.","volume":"47","author":"Motegi","year":"2020","journal-title":"J Dermatol"},{"key":"R16-20251121","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s10067-024-06965-w","article-title":"Association between anti-PL7 antibodies and increased fibrotic component in patients with antisynthetase syndrome and interstitial lung disease: a cross-sectional study.","volume":"43","author":"Rivero-Gallegos","year":"2024","journal-title":"Clin Rheumatol"},{"key":"R17-20251121","first-page":"101686","article-title":"Intravenous immunoglobulin treatment stabilizing a patient with anti-PL7 antisynthetase syndrome with interstitial lung disease and eosinophilic inflammation.","volume":"38","author":"Peshbahar","year":"2022","journal-title":"Respir Med Case Rep"},{"key":"R18-20251121","doi-asserted-by":"crossref","first-page":"e36880","DOI":"10.1016\/j.heliyon.2024.e36880","article-title":"Case report: antisynthetase syndrome with positive anti-PL7\/SSA\/RO52 antibodies.","volume":"10","author":"Ding","year":"2024","journal-title":"Heliyon"},{"key":"R19-20251121","doi-asserted-by":"crossref","first-page":"283","DOI":"10.21037\/atm-21-2434","article-title":"Detection of paraneoplastic antibodies and their significance in paraneoplastic neurologic syndromes: a narrative review.","volume":"11","author":"Li","year":"2023","journal-title":"Ann Transl Med"},{"key":"R20-20251121","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-12-823912-4.00007-4","article-title":"Clinical approach to diagnosis of paraneoplastic neurologic syndromes.","volume":"200","author":"Graus","year":"2024","journal-title":"Handb Clin Neurol"},{"key":"R21-20251121","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/B978-0-12-823912-4.00021-9","article-title":"Paraneoplastic antibodies targeting intracellular antigens.","volume":"200","author":"Linnoila","year":"2024","journal-title":"Handb Clin Neurol"},{"key":"R22-20251121","first-page":"e36538","article-title":"Paraneoplastic necrotizing myopathy associated with metastatic colon cancer: a case report.","volume":"15","author":"Ashish","year":"2023","journal-title":"Cureus"},{"key":"R23-20251121","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.3390\/diagnostics13193080","article-title":"Detection of myositis autoantibodies by multi-analytic immunoassays in a large multicenter cohort of patients with definite idiopathic inflammatory myopathies.","volume":"13","author":"Ghirardello","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R24-20251121","doi-asserted-by":"crossref","first-page":"200","DOI":"10.31138\/mjr.300525.iao","article-title":"Clinical profile and outcomes in anti-TIF1\u03b3 positive idiopathic inflammatory myositis patients: a greek cohort study.","volume":"36","author":"Syrmou","year":"2025","journal-title":"Mediterr J Rheumatol"},{"key":"R25-20251121","doi-asserted-by":"crossref","first-page":"1525432","DOI":"10.3389\/fimmu.2025.1525432","article-title":"Anti-synthetase syndrome with anti-PL-7 antibody positive in a child: a case report and literature review.","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"R26-20251121","doi-asserted-by":"crossref","first-page":"802499","DOI":"10.3389\/fimmu.2022.802499","article-title":"Machine learning algorithms identify clinical subtypes and cancer in anti-TIF1\u03b3+ myositis: a longitudinal study of 87 patients.","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"R27-20251121","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/rheumatology\/keac115","article-title":"British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy.","volume":"61","author":"Oldroyd","year":"2022","journal-title":"Rheumatology (Oxford)"},{"journal-title":"Intern Med","article-title":"Differences in organ damage based on age at onset in idiopathic inflammatory myopathies: a retrospective multicenter MYKO study [published online ahead of print May 15, 2025].","author":"Tsuji","key":"R28-20251121"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:03:38Z","timestamp":1763766218000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":28,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046170","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"2025-06-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}